This article focuses on observed short-term impacts, adaptations and the longer-term outlook for cancer screening in relation to COVID-19. It summarises potential responses to minimise the harms of disruptions caused by COVID-19, and highlights research and policy opportunities in the pandemic response and recovery which...

Australia was one of the frst countries to make the transition from cytology-based to HPV-based cervical screening.This analysis of the national program’s transition to a new model looks at the lessons learnt that can provide valuable insights to other settings.

Starting cervical cancer screening at age 25 is safe. The findings support the Australian government’s renewed cervical screening program (set to come into effect in May 2017), which recommends that women should start screening for cervical cancer at age 25, not age 18-20. Abstract: The...